跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23 条关于
“eMTBR-tau243”
全部
23
临床试验
9
药物
2
机构
1
资讯
11
3个月前
PET Imaging and Blood Biomarker Studies Advance Toward First In-Life Diagnosis of Chronic Traumatic Encephalopathy
2个月前
Spear Bio to Unveil First Commercially Available Singleplex eMTBR-Tau Immunoassay and Novel pTau 217 Assay at AAIC 2026
去年
Eisai's Anti-MTBR Tau Antibody E2814 Shows Promise in Early Alzheimer's Disease
去年
Eisai's Anti-MTBR Tau Antibody E2814 Shows Promise in Alzheimer's Disease
去年
Eisai's Tau Antibody Etalanetug Receives FDA Fast Track Designation for Alzheimer's Disease
9个月前
LEQEMBI Shows Measurable Target Engagement with Alzheimer's Protofibrils in Cerebrospinal Fluid
9个月前
Roche's Trontinemab Shows 92% Amyloid Clearance Success in Alzheimer's Mid-Stage Trial
去年
Alzheimer's Disease Therapeutics: Donanemab Dosing, Anti-Tau Antibody E2814, and Combination Intranasal Insulin/Empagliflozin Show Promise
去年
Key Neurology Advances of 2024: From Novel Therapies to Trial Innovations
3个月前
Alzheimer's Biomarker p-tau217 May Identify Women at Higher Dementia Risk from Combined Hormone Therapy
第 1 页,共 2 页
上一页
下一页